NCT06969287View on ClinicalTrials.gov

Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2028

Conditions
DeliriumSurgery-Complications
Interventions
DRUG

Fluvoxamine

"100mg Fluvoxamine Capsule~1. Day of surgery - Study drug to be taken morning of surgery and evening of surgery~2. Post-operative day 1 - Study drug to be taken morning and evening"

DRUG

Placebo

"Placebo Capsule~1. Day of surgery - Study drug to be taken morning of surgery and evening of surgery~2. Post-operative day 1 - Study drug to be taken morning and evening"

Trial Locations (1)

63110

Washington University School of Medicine/Barnes-Jewish Hospital, St Louis

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Washington University School of Medicine

OTHER